Elucid Bioimaging Inc. research brief
CIK 1585931
Generated Nov. 17, 2026, 11:54 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: BOSTON Massachusetts. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Oct. 27, 2026 · D/A · 0002080612-26-000057 · Source evidence
Reported offering amount: 79999999 USD. Reported amount sold: 56235000 USD.
- Oct. 22, 2025 · D · 0002080612-25-000007 · Source evidence
Reported offering amount: 79999999 USD. Reported amount sold: 36495008 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Elucid Bioimaging Inc. research brief,” CIK 1585931, retrieved Nov. 17, 2026, 11:54 p.m.. Cite the specific accessions used. No amounts have been summed.